Clinical Research Open Access
Copyright ©The Author(s) 2003. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 2003; 9(9): 2092-2095
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2092
Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume
Yi-Ming Li, Fan Lv, Xin Xu, Hong Ji, Wen-Tao Gao, Tuan-Jie Lei, Gui-Bing Ren, Zhi-Lan Bai, Qiang Li, General Surgery Department, the 2nd Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, ShaanXi Province, China
Author contributions: All authors contributed equally to the work.
Supported by Natural Science Foundation of Shaanxi Province, No. 99SM61
Correspondence to: Yi-Ming Li, General Surgery Department, the 2nd Hospital of Xi’an Jiaotong University, 710004, Xi’an, Shaanxi Province, China. liyiming@yahoo.com.cn
Telephone: +86-29-7276936-29246
Received: January 14, 2003
Revised: January 23, 2003
Accepted: March 10, 2003
Published online: September 15, 2003

Abstract

AIM: Our research attempted to evaluate the overall functional reserve of cirrhotic liver by combination of hepatic functional blood flow, liver volume, and Child-Pugh’s classification, and to discuss its value of clinical application.

METHODS: Ninety two patients with portal hypertension due to hepatic cirrhosis were investigated. All had a history of haematemesis and hematochezia, esophageal and gastric fundus varices, splenomegaly and hypersplenia. A 2-year follow-up was routinely performed and no one was lost. Twenty two healthy volunteers were used as control group. Blood and urine samples were collected 4 times before and after intravenous D-sorbitol infusion. The hepatic clearance (CLH) of D-sorbitol was then calculated according to enzymatic spectrophotometric method while the total blood flow (QTOTAL) and intrahepatic shunt (RINS) were detected by multicolor Doppler ultrasound, and the liver volume was measured by spiral CT. Data were estimated by t-test, variance calculation and chi-squared test. The relationships between all these parameters and different groups were investigated according to Child-Pugh classification and postoperative complications respectively.

RESULTS: Steady blood concentration was achieved 120 mins after D-sorbitol intravenous infusion, which was (0.358 ± 0.064) mmol·L-1 in cirrhotic group and (0.189 ± 0.05) mmol·L-1 in control group (P < 0.01). CLH = (812.7 ± 112.4) mL·min-1, QTOTAL = (1280.6 ± 131.4) mL·min-1, and RINS = (36.54 ± 10.65)% in cirrhotic group and CLH = (1248.3 ± 210.5) mL·min-1, QTOTAL = (1362.4 ± 126.9) mL·min-1, and RINS = (8.37 ± 3.32)% in control group (P < 0.01). The liver volume of cirrhotic group was 1057 ± 249 cm3, 851 ± 148 cm3 and 663 ± 77 cm3 in Child A, B and C group respectively with significant difference (P < 0.001). The average volume of cirrhotic liver in Child B, C group was significantly reduced in comparison with that in control group (P < 0.001). The patient, whose liver volume decreased by 40% with the CLH below 600 mL·min-1, would have a higher incidence of postoperative complications. There was no strict correspondent relationship between CLH, liver volume and Child-Pugh’s classification.

CONCLUSION: The hepatic clearance of D-sorbitol, CT measured liver volume can be reliably used for the evaluation of hepatic functional blood flow and liver metabolic volume. Combined with the Child-Pugh’s classification, it could be very useful for further understanding the liver functional reserve, therefore help determine reasonable therapeutic plan, choose surgical procedures and operating time.




INTRODUCTION

Accurate evaluation of the hepatic functional reserve is very important in the development of hepatobiliary surgery. Hepatic functional reserve means the whole functions of all hepatic parenchyma cells, which depend on the interaction between relatively healthy hepatic cells and blood perfusion. Based on Child-Pugh’s classification, we have established a new method to evaluate the liver functional reserve by D-sorbitol clearance rate indicating hepatic functional blood flow and CT measured liver volume indicating normal hepatic metabolic volume.

MATERIALS AND METHODS
Materials

Ninety two patients with portal hypertension due to hepatic cirrhosis, were selected in our hospital from March 1999 to January 2001, including 57 males and 35 females aged between 20-66 years, with a mean age 43.5 ± 11.8 years. All of them had a history of haematemesis and hematochezia, and moderate esophageal varices were found in 41 patients and severe ones in 51 patients by gastroscopy. Porta-azygous devascularization was applied to all patients and the pathological diagnosis was confirmed by biopsy during the surgical procedure. According to Child-Pugh’s classification, 36 cases were scored as A, 39 as B and 17 as C. A 2-year follow-up was routinely performed. The healthy control group consisted of 20 volunteers, 11 males and 9 females, who had no abnormality in CT scan and related history of liver disease.

The postoperative data of operative complications and hepatic functions were carefully recorded and a routine follow-up was given. There was no operative mortality, severe complications occurred in 31 cases because of liver function deterioration after the operation, including 13 cases of long standing jaundice, 7 hepatic coma, 13 severe ascites, and 6 recurring hemorrhage of upper GI tract.

Methods

Intravenous infusion of D-sorbitol and collection of blood and urine samples Controlled by the peristalsis pump, 5% D-sorbitol solution was continuously infused intravenously for 3 hours at a rate of 1 mL·min-1 (a dose of 50 mg·min-1). The samples of blood (3 mL), urine and the volumes at the same time were collected and recorded once before infusion and 3 times at 120, 150, 180 min after infusion.

Determination of D-sorbitol concentration and calculation The enzymatic spectrophotometric method was used to determine the D-sorbitol concentration in blood and urine[1,2]. The total D-sorbitol clearance rate (CLTOTAL), renal D-sorbitol clearance rate (CLREN) and liver D-sorbitol clearance rate (CLH) were calculated according to the formula reported[3,4] as CLTOTAL = R ÷ Css and CLREN = U ÷ Css. (R: D-sorbitol infusion rate; Css: homeostatic plasma concentration; U: average urinary excretion rate, (CLH = CLTOTAL - CLREN).

Hepatic total blood flow (QTOTAL) and intrahepatic shunt rate (RINS) and liver extraction rate (E) assay and calculation The angle between blood flow and Doppler ultrasound wave direction was controlled below 60 degrees, the mean blood flow rates of three main liver veins (left, middle, right hepatic vein) were carefully detected by ultrasonic equipment. Then, the accurate blood flow of each vein was calculated according to the formula as Q = 1/4πD2× 60 × Vmean[5,6], and their sum was the total blood flow (QTOTAL). The D-sorbitol hepatic clearance rate equaled to the liver functional blood flow (QFUNC), and RINS = (QTOTAL - QFUNC)/QTOTAL. According to Fick’s rule[7,8], the hepatic extractive rate E = CLH/QTOTAL.

Method for measuring liver volume change by CT Guided by the reported method[9], the cirrhotic liver volume was measured by CT (PQ6000), at the same time the expected “normal” liver volume of the patient was calculated according to the reported formula[10]. The volume change rate (R) was then calculated according to the formula: (CT measured LV - expected LV)/expected LV × 100%.

Statistical analysis

The relationship between liver functional blood flow, liver volume change rate, Child-Pugh’s classification, postoperative complication rate was investigated.Data were expressed as mean ± S. Statistical significance was estimated by t-test. The multiple means between various groups were estimated by variance calculation. The difference of percentage was estimated by chi-squared test.

RESULTS
Changes of D-sorbitol clearance index in two groups

Table 1 shows that the D-sorbitol plasma concentration of each group could come to a stable level after continuous intravenous infusion for 120 minutes. The homeostatic plasma concentration of control group was (0.189 ± 0.05) mmol·L-1, and that of hepatic cirrhotic group was (0.358 ± 0.064) mmol·L-1. The difference between the two groups was significant (P < 0.01). The total liver blood flow between the two groups had no significant difference. The D-sorbitol liver extraction rate and hepatic clearance rate decreased significantly while intrahepatic shunt flow increased significantly in the cirrhotic group. All reached statistical significance compared with that of the control group.

Table 1 Indexes of D-sorbitol clearance (mean ± s).
GroupsnCss (mmol·L-1)RINS (%)CLH(QFUNC) (mL·min-1)E (%)QTOTAL (mL·min-1)
Control200.189 ± 0.058.37 ± 3.321248.3 ± 210.591.6 ± 6.51362.4 ± 126.9
Cirrhotic920.385 ± 0.064a36.54 ± 10.65812.7 ± 112.4a63.5 ± 9.4a1280.6 ± 131.4
Relationship between Child-Pugh’s classification and D-sorbitol liver clearance rate and liver volume change rate

Table 2 shows that there was a clear correlation between each Child-Pugh’s classification group and D-sorbitol liver clearance rate and liver volume, respectively. The higher the Child-Pugh’s classification degree, the lesser the liver functional blood flow, the more the intrahepatic shunt flow, and the smaller the mean liver volume. The difference had statistical significance between each group (P < 0.05).

Table 2 Relationship between Child-Pugh’s classification and D-sorbitol liver clearance rate and liver volume change rate.
Child-Pugh’s classificationnCLH (mL·min-1)QINS (%)Mean cirrhotic liver volume (cm3)
A36995.8 ± 174.822.2 ± 4.21057 ± 249
B39783.4 ± 120.6a38.8 ± 7.3a851 ± 148a
C17548.6 ± 32.8b57.8 ± 6.6b663 ± 77b

Table 3 shows in view of individual patient, there was not any complete correlation between the D-sorbitol liver clearance rate and liver volume change rate or liver function status in cirrhotic patients. Even in the same Child-Pugh’s classification group, the D-sorbitol clearance rate and liver volume change rate varied remarkably. It was found that a mild Child’s classified patient could have a low D-sorbitol clearance rate and a small liver volume, and vice versa.

Table 3 Correlative relationship between hepatic D-sorbitol clearance rate and liver volume change rate and Child-Pugh’s classification.
Child-Pugh’s classificationCLH (mL·min-1)
Liver volume change rate
> 800600-800< 600R ≥ -20%-40% < R < -20%R ≤ -40%
A(case)2111420133
B(case)82479264
C(case)06112510
Relationship between postoperative complications and D-sorbitol clearance rate and liver volume change rate

Table 4 shows that severe postoperative complications increased steadily as the D-sorbitol clearance rate and/or liver volume decreased. When the CLH was below 600/mL·min-1, R below -40%, the incidence of severe complications was higher than 70% (P < 0.05).

Table 4 Relationship between hepatic D-sorbitol clearance rate and liver volume change rate and postoperative compli-cations.
Postoperative complicationsCLH (mL·min-1)
Liver volume change rate
> 800600-800< 600R ≥ -20%-40% < R < -20%R ≤ -40%
Case number294122314417
Complication cases1141631612
Rate (%)3.434.2a72.7b9.736.4a70.6b

Table 5 shows that 22 cases had a D-sorbitol clearance rate lower than 600/mL·min-1. 8 of them had their liver volume change rate between -20% and -40%, 14 below -40%, and the incidences of postoperative complications were 62.5% (5/8), and 78.6% (11/14), respectively.

Table 5 Correlation between hepatic D-sorbitol clearance rate and liver volume change rate and operation complications.
CLH (mL·min-1)-40% < R < -20%
R ≤ -40%
NumberComplication caseComplication rateNumberComplication caseComplication rate
600-800351234.3(%)3133.3(%)
< 6008562.5(%)141178.6(%)
DISCUSSION

It is essential in the surgical treatment of portal hypertension, to evaluate accurately the patient’s preoperative liver functional reserve and to make a reasonable peri-operative therapeutic plan in order to choose the best surgical procedures and to increase its efficacy. The Child-Pugh’s classification is still the most important method to determine the type and time of operation, and is widely accepted for the patients who are in stage I or II. But there are relatively high-risks for post-operative complications and mortality[11-13]. This is because the present classification cannot completely reflect the injured and whole hepatic function, besides the technical factors[14-16]. What condition would go worse with the operative burden is another factor that is difficult to tell. It is therefore necessary to find more objective criteria for the evaluation of hepatic functional reservation.

The liver inherent metabolic volume and blood flow determine its functions in most occasions, which also depend on the relative ratio and mutual influence of the two factors[17-20]. When cirrhosis and portal hypertension occur, necrosis of liver cells, hyperplasia of fibrous tissue, formation of pseudo lobules and abnormality of liver microcirculation will result in decrease of liver inherent metabolic volume, increase of anatomical and physiological intrahepatic shunt and change of their relevant ratio[21]. Therefore, measurement of liver inherent metabolic volume and functional blood flow can provide more information on the understanding of physiological changes and functional reserve of the cirrhotic liver, and help to make individualized and reasonable therapeutic decisions.

Liver functional blood flow is a part of total liver blood flow that enters the hepatic sinusoid involved in the metabolic process[1]. Currently it can only be measured by assay of its clearance rate. D-sorbitol is the first substance suitable for noninvasive evaluation of hepatic blood flow, and is widely used to observe the normal and pathologic perfusion of the liver outside China[22]. Molino, Susanne et al[8,23], reported that the normal liver had a very high D-sorbitol extraction rate of around 94%, and CLH could be used to represent the liver total blood flow (QTOTAL), and its variation could reflect the change of liver blood flow. In our research, D-sorbitol clearance rate and color Doppler ultrasonography were used to study the liver blood flow. It was found that D-sorbitol plasma concentration of the healthy control group always came to homeostasis by continuously intravenous infusion after 120 minutes (0.189 ± 0.05 mmol/l), CLH was 1248.3 ± 210.5/mL·min-1, QTOTAL was 1362.4 ± 126.9/mL·min-1 and the D-sorbitol extraction rate of the liver was 91.6 ± 6.5%. The D-sorbitol extraction rate decreased dramatically to 63.5 ± 9.4% in the cirrhotic group, which was statistically significant compared with that of control group (P < 0.01). The CLH, reflecting the liver functional blood flow[1,11,24], was 812.7 ± 112.4/mL·min-1 significantly different from that of the control group (P < 0.01). The RINS was 8.37 ± 3.32% in control group and was 36.54 ± 10.65% in cirrhotic group (P < 0.01). The intrahepatic shunt consisted of anatomical shunt and physiological shunt, and the latter had no help to hepatic function even passing through hepatic sinusoid[25]. Therefore, the combination of D-sorbitol clearance rate and color Doppler ultrasonography can show the liver functional blood flow and the conditions of intrahepatic shunt which are so meaningful for the evaluation of liver blood flow in the liver functional reserve before proper medication is given[26,27]. Our conclusion is that D-sorbitol clearance rate can be widely used in clinical practice, which is safe, economical, practicable, and noninvasive.

The liver inherent metabolic volume and liver functional blood flow are complementary to each other, especially their matching. It is a mature and repeatable method to use CT in measuring liver volume[28-30]. Liver volume is considered as a liver function index as important as the Child-Pugh’s classification because it can partly represent the hepatic parenchyma cell volume[31-33]. Combining liver volume measured by CT scanning and an expected “normal” liver volume calculated according to a standard liver volume formula[8], the cirrhotic liver volume change rate has been measured quantitatively. The Child-Pugh’s liver function classification is a classic liver function index and is widely used in clinical practice. Our research results demonstrated that the indexes for liver inherent metabolic volume and liver functional blood flow could be used as a complement to Child-Pugh’s classification to gain overall and objective data of liver functional reserve. The CLH, RINS and liver volume change rate had some correlations with the Child-Pugh’s classification. The higher the Child-Pugh’s classification, was the less the liver functional blood flow existed, the more the intrahepatic shunt occurred, the smaller the liver volume was. This result is comparable with other reports[34,35]. It was also found that variation of CLH and liver volume change rate did not always correlate with each other even the Child-Pugh’s classification was the same. There was an overlap among different groups, indicating that a patient classified as Child A might have a smaller CLH and liver volume than a patient classified as Child B or C. This may explain why some deadly complications such as severe ascites or hepatic coma might occur in Child-Pugh’s A patients but not in Child-Pugh’s B or C patients after operation. In conclusion, the functional blood flow and cirrhotic liver volume are two critical indexes which are complementary to Child-Pugh’s classification and can help the evaluation of the overall status of cirrhotic liver and the establishment of individualized therapeutic plan[17,18,30,31].

The CLH and liver volume change rate had a close relationship with the postoperative complications in cirrhotic patients. The complication incidence increased as the CLH or liver volume change rate decreased. The complication rate exceeded 70% (P < 0.05) when CLH was below 600/mL·min-1 or R below 40%. This can be explained by the theory that the liver can not stand anesthesia and operative risks when decreased metabolic volume and functional blood flow have already put the liver at the edge of collapse. The CLH and liver volume change rate could be complementary to each other when postoperative complications were to be predicted. 22 cases had D-sorbitol clearance rate lower than 600/mL·min-1. 8 of them had their liver volume change rate between -20% and -40%, 14 below -40%. The incidence of postoperative complications was 62.5% (5/8) and 78.6% (11/14), respectively. Therefore, the Child-Pugh’s classification complemented by CLH and liver volume change rate should be used to determine the surgical time and type. When the liver has a better functional blood flow with liver volume compensated, the portal-systemic shunt or combination operation can be performed. When the functional blood flow and/or liver volume are decreased dramatically, the treatment of perioperative period should be strengthened to increase the tolerance of the cirrhotic liver, and porta-azygous devascularization would be more suitable. When CLH < 600/mL·min-1, R < -40%, conservative therapy should be recommended. If no improvement of these indexes is achieved after that, the patients should be considered as the end stage of liver cirrhosis and liver transplantation should be possibly considered.

Footnotes

Edited by Xu JY, Zhu LH and Wang XL

References
1.  Molino G, Avagnina P, Belforte G, Bircher J. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. J Lab Clin Med. 1998;131:393-405.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 23]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
2.  Clemmesen JO, Tygstrup N, Ott P. Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy: evaluation of indocyanine green and D-sorbitol as test substances. Hepatology. 1998;27:666-673.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 24]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
3.  Sinha V, Brendel K, Mayersohn M. A simplified isolated perfused rat liver apparatus: characterization and measurement of extraction ratios of selected compounds. Life Sci. 2000;66:1795-1804.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
4.  Rosemurgy AS, Norman JG, Goode SE. Does the direction of portal blood flow determine outcome with small-diameter prosthetic H-graft portacaval shunt. Surgery. 1997;121:95-101.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
5.  Fabbri A, Magalotti D, Brizi M, Bianchi G, Zoli M, Marchesini G. Prostaglandin E1 infusion and functional hepatic flow in control subjects and in patients with cirrhosis. Dig Dis Sci. 1999;44:377-384.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
6.  Sugimoto H, Kaneko T, Inoue S, Takeda S, Nakao A. Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation. Hepatogastroenterology. 2002;49:793-797.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Le Couteur DG, Hickey H, Harvey PJ, Gready J, McLean AJ. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. J Pharmacol Exp Ther. 1999;289:1553-1558.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Keiding S, Engsted E, Ott P. Sorbitol as a test substance for measurement of liver plasma flow in humans. Hepatology. 1998;28:50-56.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 18]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
9.  Kayaalp C, Arda K, Oto A, Oran M. Liver volume measurement by spiral CT: an in vitro study. Clin Imaging. 2002;26:122-124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 26]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
10.  Urata K, Hashikura Y, Ikegami T, Terada M, Kawasaki S. Standard liver volume in adults. Transplant Proc. 2000;32:2093-2094.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 49]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
11.  Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90:42-53.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 261]  [Cited by in F6Publishing: 275]  [Article Influence: 11.0]  [Reference Citation Analysis (0)]
12.  Rizvon MK, Chou CL. Surgery in the patient with liver disease. Med Clin North Am. 2003;87:211-227.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 32]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
13.  Pisani Ceretti A, Cordovana A, Pinto A, Spina GP. [Surgery in the cirrhotic patient. Prognosis and risk factors]. Minerva Chir. 2000;55:771-778.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Fan ST. Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. Hepatogastroenterology. 2002;49:17-20.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Wu CC, Yeh DC, Lin MC, Liu TJ, P'Eng FK. Improving operative safety for cirrhotic liver resection. Br J Surg. 2001;88:210-215.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 43]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
16.  Pagliaro L. MELD: the end of Child-Pugh classification. J Hepatol. 2002;36:141-142.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 44]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
17.  Hashimoto M, Watanabe G. Simultaneous measurement of effective hepatic blood flow and systemic circulation. Hepatogastroenterology. 2000;47:1669-1674.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Zipprich A, Steudel N, Behrmann C, Meiss F, Sziegoleit U, Fleig WE, Kleber G. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology. 2003;37:385-392.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 44]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
19.  Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, Tuorto S, Blumgart LH, Fong Y. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325-330.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 350]  [Cited by in F6Publishing: 327]  [Article Influence: 15.6]  [Reference Citation Analysis (0)]
20.  Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96:541-546.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 78]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
21.  Bläker H, Theuer D, Otto HF. [Pathology of liver cirrhosis and portal hypertension]. Radiologe. 2001;41:833-839.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
22.  Burggraaf J, Schoemaker RC, Lentjes EG, Cohen AF. Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers. Eur J Pharm Sci. 2000;12:133-139.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
23.  Garello E, Battista S, Bar F, Niro GA, Cappello N, Rizzetto M, Molino G. Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. Dig Dis Sci. 1999;44:782-788.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 26]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
24.  Zoli M, Magalotti D, Bianchi G, Ghigi G, Orlandini C, Grimaldi M, Marchesini G, Pisi E. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol. 1995;23:129-134.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 50]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
25.  Koranda P, Myslivecek M, Erban J, Seidlová V, Husák V. Hepatic perfusion changes in patients with cirrhosis indices of hepatic arterial blood flow. Clin Nucl Med. 1999;24:507-510.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
26.  Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ. The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl. 1999;230:82-88.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Piscaglia F, Donati G, Serra C, Muratori R, Solmi L, Gaiani S, Gramantieri L, Bolondi L. Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension. Ultrasound Med Biol. 2001;27:893-899.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 38]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
28.  Imsamran W, Leelawat K, Leelawat T, Subwongcharoen S, Ratanachu-ek T, Treepongkaruna SA. Simple technique in the measurement of liver volume. J Med Assoc Thai. 2003;86:151-156.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Usuki N, Miyamoto T. Chronic hepatic disease: usefulness of serial CT examinations. J Comput Assist Tomogr. 2002;26:418-421.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
30.  Sandrasegaran K, Kwo PW, DiGirolamo D, Stockberger SM, Cummings OW, Kopecky KK. Measurement of liver volume using spiral CT and the curved line and cubic spline algorithms: reproducibility and interobserver variation. Abdom Imaging. 1999;24:61-65.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 46]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
31.  Lin XZ, Sun YN, Liu YH, Sheu BS, Cheng BN, Chen CY, Tsai HM, Shen CL. Liver volume in patients with or without chronic liver diseases. Hepatogastroenterology. 1998;45:1069-1074.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Schiano TD, Bodian C, Schwartz ME, Glajchen N, Min AD. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation. 2000;69:545-550.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 98]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
33.  Dunkelberg JC, Feranchak AP, Fitz JG. Liver cell volume regulation: size matters. Hepatology. 2001;33:1349-1352.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 29]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
34.  Zhu JY, Leng XS, Dong N, Qi GY, Du RY. Measurement of liver volume and its clinical significance in cirrhotic portal hypertensive patients. World J Gastroenterol. 1999;5:525-526.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Hoshida Y, Shiratori Y, Koike Y, Obi S, Hamamura K, Teratani T, Shiina S, Omata M. Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma. Hepatogastroenterology. 2002;49:451-455.  [PubMed]  [DOI]  [Cited in This Article: ]